Device Trial Radar · NCT06120205
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
Last checked: Nov 19, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
870
Planned (sponsor's estimate)
Start
Nov 20, 2023
Primary completion
Apr 5, 2024
Study completion Jun 1, 2027
Sponsor
- Lead sponsor
- Teal Health, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 7, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- Female only, from 25 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this method comparison study is to compare the detection of hrHPV collected using the Teal Wand Self-Collection device to hrHPV detected from HCP (health care provider) cervical collection using primary HPV testing assays. Participants will be asked to use the Teal Wand to provide a self-collected sample prior to a healthcare provider collected sample to be tested for hrHPV. Secondary measure will include usability and preferences.
Conditions
- Hpv
- HPV 16 Infection
- HPV Infection
- High Risk HPV
Interventions
Teal Wand Self-Collection Device GroupDevice
Participants will use the Instructions for Use to perform self-collection of vaginal cells and material using the Teal Wand Self-Collection Device, and will fill out a usability survey and a satisfaction and needs survey. A healthcare provider collected sample will be performed by a clinician after self-collection. The patient will serve as their own comparator/control.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy: Detection of hrHPV in self-collect and clinician collect samplesTime frame: Samples tested within 7 days of collection
- Safety: SAE rateTime frame: 6-14 days following collections
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Birmingham OBGYN / Alabama Clinical Therapeutics
Birmingham, Alabama
Planned Parenthood Northern California
San Francisco, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.